Utilizzo:
Fa parte del modulo variabile.
Si utilizza nelle patologie neoplastiche con un dosaggio di 1-2 capsule al giorno da 10-20 microgrammi, senza superare i 40 microgrammi.


Caratteristiche farmacologiche:
È un analogo strutturale di un amminoacido essenziale, la metionina, in cui l’atomo di zolfo è sostituito da uno di selenio. Le caratteristiche biochimiche di metionina e selenio-metionina sono simili. La seleniometionina radiomarcata (L Seleniometionina[75Se]), gamma emittente, è indicata in radiodiagnostica, soprattutto per la scintigrafia del pancreas, paratiroidi, parotide e prostata. Per spiegare il razionale dell’impiego del selenio, consideriamo brevemente la perossidazione lipidica, processo bifasico comprensivo dell’iniziazione e propagazione. La prima è prodotta da radiazioni ionizzanti o radicali liberi; in essa si verifica l’estrazione di un idrogeno dal gruppo CH2 della catena alchilica con liberazione di un radicale lipidico, e successivamente la produzione di un perossido lipidico per ossigenazione. La seconda fase, la propagazione, è attivata da reazioni a catena con altri lipidi dei composti prodotti dall’iniziazione. L’omeostasi biologica antiossidante si articola su meccanismi enzimatici e antiossidanti, i quali ultimi intervengono quando sono saturate le possibilità enzimatiche. I meccanismi antiossidanti a loro volta si distinguono in preventivi, limitanti la fase di iniziazione delle reazioni ossidative, e quelli che intervengono interrompendo la propagazione. La vitamina E e analoghi esercitano la massima attività biologica, mentre la Vitamina C interviene favorendo la rigenerazione della vitamina E, il cui rapporto con le molecole fosfolipidiche nelle biomembrane è pari a 1/ 2-3000. La vitamina C interviene sulle reazioni ossidative interagendo con i radicali liberi in funzione inibitrice di nuovi prodotti dell’ossidazione. Il coinvolgimento del selenio nell’enzima glutatione – per ossidasi spiega l’interazione tra selenio e vit. E. Infatti la glutatione- per ossidasi può rigenerare la forma naturale della vitamina E dopo ossidazione [Tarozzi “Ruolo fisiologico degli acidi grassi polinsaturi” (Skepsis I,1-1999.20-37).] La Selenio-metionina deriva dalla sintesi dell’elemento chimico selenio con un amminoacido, la metionina, che svolge per le sue proprietà di metilante, attività epatoprotettiva. Nei dosaggi giornalieri di 20-40 microgrammi è utilizzato soprattutto in neoplasie polmonari, epatiche o in tumori complicati da patologie degenerative. La molecola, idrosolubile, è utile per potenziare gli effetti antiossidanti e antiradicali liberi di vitamine e melatonina, oltre che per le sue proprietà citostatiche. La sintesi con la metionina consente di utilizzare questi effetti positivi del selenio senza danni epatici. Sono numerosi gli studi clinici su varie patologie tumorali, in particolare i riscontri positivi sono più evidenti e numerosi nei tumori polmonari, prostatici e del colon.

Documenti Associati:
 
Per visualizzarne il contenuto è sufficiente collegarsi alla Banca Dati PubMed (clicca quì) riportando, con un semplice copia/incolla, il titolo della singola pubblicazione nell’apposita stringa di ricerca.
 
  • A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
  • A prospective study of plasma selenium levels and prostate cancer risk.
  • Adjuvant systemic therapies in early-stage non-small-cell lung cancer
  • An ideal ocular nutritional supplement?
  • An improved procedure for autologous gene-modified cancer vaccine preparation for active specific immunotherapy of disseminated solid tumors.
  • An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status.
  • An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum.
  • Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis.
  • Antioxidants block prostate cancer in lady transgenic mice.
  • Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds.
  • Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture.
  • Chemoprevention of lung cancer--from biology to clinical reality.
  • Chemoprevention of lung cancer. A review about previous studies, results and future developments.
  • Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
  • Chemoprevention of prostate cancer.
  • Chemoprevention possibilities of lung cancer
  • Chemotherapeutic prevention studies of prostate cancer.
  • Clinical trials in cancer prevention: current results and perspectives for the future.
  • Colorectal cancer prevention.
  • Combined effect of sodium selenite and campthotecin on cervical carcinoma cells
  • Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor, and postinflammatory hyperpigmentation.
  • Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene)selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse.
  • Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium.
  • Current status of selenium and other treatments for secondary lymphedema.
  • Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers.
  • Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies.
  • Dietary antioxidants and human cancer.
  • Dietary supplementation with high-selenium soy protein reduces pulmonary metastasis of melanoma cells in mice.
  • Effect of dietary selenite on N-nitrosodiethylamine-induced and phenobarbital promoted multistage hepatocarcinogenesis in rat: reflection in some minerals.
  • Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
  • Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial.
  • High dietary intake of sodium selenite induces oxidative DNA damage in rat liver.
  • How HIV-1 causes AIDS: implications for prevention and treatment.
  • Inhibition of DMBA-croton oil two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate through modulation of cutaneous oxidative stress and inhibition of nitric oxide production.
  • Inorganic selenium retards progression of experimental hormone refractory prostate cancer.
  • Is antioxidant use protective of cognitive function in the community-dwelling elderly?
  • Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
  • Is there any role for prevention strategies for colorectal cancer other than population-based screening?
  • Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women.
  • Mechanisms of mammary cancer chemoprevention by organoselenium compounds.
  • Mechanisms of selenium-mediated protection from photocarcinogenesis and cell death are not solely p53-dependent.
  • Mediterranean diet, micronutrients and prostate carcinoma: a rationale approach to primary prevention of prostate cancer.
  • Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.
  • Potential pathologic markers for prostate chemoprevention studies
  • Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
  • Prostate cancer chemoprevention: an overview of United States trials.
  • Prostate cancer prevention: what do we know now and when will we know more?
  • Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.
  • Review article: chemoprevention of colorectal cancer.
  • Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
  • Role of iodine in antioxidant defence in thyroid and breast disease.
  • Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts.
  • Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system.
  • Selenium and colorectal adenoma: results of a pooled analysis.
  • Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats.
  • Selenium and its relationship to cancer: an update dagger.
  • Selenium and selenomethionine levels in prostate cancer patients.
  • Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
  • Selenium biochemistry and cancer: a review of the literature.
  • Selenium compounds regulate p53 by common and distinctive mechanisms.
  • Selenium in the treatment of head and neck lymphedema.
  • Selenium levels of patients with newly diagnosed prostate cancer compared with control group.
  • Selenium supplementation enhances low selenium levels and stimulates glutathione peroxidase activity in peripheral blood and distal colon mucosa in past and present carriers of colon adenomas.
  • Selenium: epidemiology and basic science.
  • Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials.
  • Status of selenium in prostate cancer prevention.
  • Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.
  • Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.
  • Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
  • The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
  • The effect of all-trans retinoid acid and sodium selenite (Na2SeO3) on VEGF and its receptor expression in HL-60 cells.
  • The effect of neem (Azadirachta indica) extract and dietary selenium on distribution of selenium in hepatocarcinogenesis induced rat.
  • The link between selenium and chemoprevention: a case for selenoproteins.
  • The role of PC-SPES, selenium, and vitamin E in prostate cancer.
  • The use of high-selenium yeast to raise selenium status: how does it measure up?
  • Update on chemoprevention of prostate cancer.
  • Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.